Alphabet shares are falling today after a downgrade at UBS. The stock – and many others – have made big gains this year on hopes for the future of AI.

We’ll talk to the analyst behind the call, who says the transition to AI search will definitely have some growing pains.

Plus, we’ve got new developments in the battle over weight loss drugs, including promise for Eli Lilly and a setback for Pfizer. We’ll tell you all you need to know.            

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.